- Investing Ideas
- Japanese Pharmaceuticals & Biotech Large Cap High Growth Potential
Japanese Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
3
1 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
3 companies
Daiichi Sankyo Company
Market Cap: JP¥5.4t
Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.
4568
JP¥2,991.50
7D
9.5%
1Y
-6.0%
Chugai Pharmaceutical
Market Cap: JP¥13.7t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥8,841.00
7D
3.0%
1Y
5.0%
Takeda Pharmaceutical
Market Cap: JP¥8.8t
Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.
New
4502
JP¥5,556.00
7D
-1.4%
1Y
31.9%